Parainfluenza Vaccine
Parainfluenza type 3 vaccine safe and effective in children
Published in Vaccine Weekly, March 31st, 2004
"A phase 2 evaluation of live attenuated parainfluenza type 3 (PIV3) -cold passage mutant 45 (cp45) vaccine was conducted in 380 children 6 to 18 months old; 226 children (59%) were seronegative for PIV3. Of the 226 seronegative children, 114 received PIV3-cp45 vaccine, and 112 received placebo. No significant difference in the occurrence of adverse events (i.e., runny nose, cough, or temperature {{>=}}38 degrees C) was noted during the 14 days after vaccination," scientists in the United States and Australia report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-03-31)
More Articles from Vaccine Weekly
- Hepatitis E Vaccine
Hepatitis E virus-like particles protect monkeys against HEV infection - Vector Development
Lentiviral vector encoding NY-ESO-1 induces effective CTL response - DNA Vaccine
Altering conditions of DNA immunization allows control of immune response - Prostate Cancer
Peptide vaccine helpful for HLA-A2-positive patients with prostate cancer - Rotavirus Vaccine
HIV-1 Tat peptide-rotavirus enterotoxin protein stimulates immune response - Schistosomiasis
IL-12 enhances immunity of Schistosoma mansoni fatty acid-binding protein - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
